Emerson Electric Tops Q3 Estimates and Lifts Full-Year Outlook
EMR sits 26% above its 52-week low of $122.635 on elevated volume (1.8× avg).
Summary
Emerson Electric's Q3 FY2026 results topped expectations, with net sales climbing 7% to $4.9B and adjusted EPS reaching $1.71, a 13% increase. The company raised its full-year adjusted EPS guidance to ~$6.55 and declared a quarterly dividend of $0.555 per share.
Key Events · Earnings and Guidance · EMR
-
Q3 Earnings Beat
Net sales hit $4.9B, up 7% year-over-year, while adjusted EPS of $1.71 rose 13% and exceeded expectations.
-
Full-Year Guidance Raised
FY2026 adjusted EPS guidance was lifted to ~$6.55, reflecting a strong Q3 performance and healthy demand.
-
Robust Cash Flow
Operating cash flow came in at $1.425B, a 34% year-over-year increase, and free cash flow reached $1.323B, up 36%.
-
Capital Return Plans
A $0.555 quarterly dividend was declared; the FY2026 outlook assumes ~$2.2B returned to shareholders via ~$1B in buybacks and ~$1.2B in dividends.
Analysis · EMR · Manufacturing
A standout Q3 saw Emerson surpass expectations across sales, margins, earnings, and cash flow. Underlying orders rose 7%, fueled by strength in Software & Systems and broad-based demand in North America and Asia. Reflecting confidence in sustained demand and secular tailwinds, management raised the full-year adjusted EPS guide to ~$6.55. The company also declared a $0.555 quarterly dividend and plans to return roughly $2.2B to shareholders in FY2026 through buybacks and dividends.
At the time of this filing, EMR was trading at $155.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $89B. The 52-week trading range was $122.64 to $165.15. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.